Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Period	Net Profit Margin
2015-12-31	5.60%
2016-12-31	1.26%
2017-12-31	5.66%
2018-12-31	15.97%
2019-12-31	76.08%
2020-12-31	149.84%
2021-12-31	145.57%
2022-12-31	-129.45%
2023-12-31	-23.86%
2024-12-31	-71.86%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BIO	$278.67	-0.47%	0.12M
3
4
5

Bio-Rad Laboratories Inc. Class A (BIO) Profit Margin

Profit Margin Data

Get Bio-Rad Laboratories Inc. Class A Data in Excel

More BIO Financial Data